No Picture
News

Inhibrx Announces Completion of Phase 1 Combination Dose Escalation for INBRX-105, a Novel Targeted 4-1BB Agonist, and Draws an Additional $60 Million from Oxford Finance

SAN DIEGO, June 30, 2022 /PRNewswire/ — Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development and a robust preclinical pipeline, today announced the completion of Phase 1 dose escalation of […]

No Picture
News

Phanes Therapeutics’ PT886 granted Orphan Drug Designation for the treatment of pancreatic cancer by the FDA

SAN DIEGO, June 30, 2022 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in oncology, announced today that the U.S. Food and Drug Administration (FDA) has granted […]

No Picture
News

Biocom California Adds to its Board of Governors

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO–(BUSINESS WIRE)–Biocom California, the association representing the California life science industry, today announced that it has appointed Joydeep Ganguly, senior vice president of corporate operations at […]

No Picture
News

Surglogs Completes SOC2 Type 1 Examination

SAN DIEGO, June 28, 2022 /PRNewswire/ — Surglogs, the nation’s leading regulatory compliance platform for healthcare facilities, has announced that it has successfully passed a System and Organization Controls (SOC) 2 Type 1 examination. The […]

No Picture
News

FRESH START SURGICAL GIFTS PARTNERS WITH SANFORD HEALTH TO EXPAND SERVICES AND FURTHER THEIR MISSION OF TRANSFORMING THE LIVES OF CHILDREN

SAN DIEGO, June 27, 2022 /PRNewswire/ — Fresh Start Surgical Gifts has partnered with Sanford Health to expand their services and further their mission to transform the lives of children and teens forever. Fresh Start […]